This podcast is a special re-issue of TWiV's 100th episode, featuring an in-depth interview with the late Nobel laureate David Baltimore (1938β2025). Baltimore recounts his career arc, beginning with his graduate work in the 1960s when the replication mechanism of RNA viruses was a major puzzle. He details his foundational discoveries, including the first RNA-dependent RNA polymerase in polio and mango viruses, and the groundbreaking 1970 identification of reverse transcriptase in retroviruses, which challenged the central dogma of molecular biology. He explains how these findings led to the Baltimore Classification system, a fundamental framework in virology. The conversation also covers the historic Asilomar conference on recombinant DNA, major paradigm shifts in biology (like the discovery of mRNA and splicing), his perspectives on contemporary challenges such as HIV vaccine development and the XMRV controversy, and offers advice for young scientists. The episode serves as both a historical retrospective of molecular virology and a reflection on the nature of scientific discovery and responsibility.
A Conversation with David Baltimore: The Foundations and Future of Virology
0:26 Introduction to a Special Episode: The podcast re-issues its 100th episode (originally from 2010) as a tribute to David Baltimore, Vincent Racaniello's post-doctoral mentor and a giant in the field of virology.
3:39 The Early Days of Virology (1960s): Baltimore describes the field in the early 60s as focused on genetics, with very little biochemistry applied to animal viruses. His central question was whether molecular biology could be used to understand them, which led to his PhD work on the poliovirus and mengovirus RNA polymerases.
7:33 The "Anomaly" of RNA Viruses: He explains that the key problem of the era was understanding how RNA viruses, which lack DNA, could replicate their genomes. The prevailing "central dogma" was DNA -> RNA -> Protein. His discovery of an RNA-dependent RNA polymerase provided the answer for viruses like polio.
12:40 Discovering the VSV Polymerase: A pivotal moment came when he began studying Vesicular Stomatitis Virus (VSV). After determining it was a negative-strand virus (its RNA is complementary to mRNA), the question became how it could start an infection. The answer was the discovery of a pre-packaged RNA polymerase inside the virus particle itself.
14:53 The Retrovirus Puzzle and Reverse Transcriptase: Baltimore recounts how RNA tumor viruses (now retroviruses) didn't fit his classification scheme. The key puzzle, posed by Howard Temin, was how an RNA virus could cause a stable transformation of a cell (i.e., cancer). This led him to look for an enzyme that could convert RNA to DNA, discovering reverse transcriptase in 1970 and confirming Temin's hypothesis.
17:34 The Baltimore Classification System: The discovery of reverse transcriptase was the final piece of the puzzle, allowing him to formulate a unified classification system for all viruses based on the pathway they use to generate messenger RNA (mRNA) from their genomes.
22:53 The Asilomar Conference on Recombinant DNA: As one of the organizers, Baltimore explains the significance of the 1975 conference. Faced with the powerful new technology of gene cloning, the scientific community called a voluntary moratorium on certain experiments to create a framework for conducting research safely and responsibly, setting a global precedent for scientific self-regulation.
33:50 Major Paradigm Shifts in Biology: When asked about the biggest conceptual shifts in his career, Baltimore names the discovery of messenger RNA (1961) as the most critical, followed by RNA splicing and the discovery of microRNAs.
40:27 Contemporary Virology Challenges: HIV and XMRV:
HIV: He discusses the immense difficulty of creating an HIV vaccine, partly because the virus has very few, widely spaced spikes, preventing antibodies from effectively neutralizing it.
XMRV: He expresses extreme caution regarding the then-current controversy linking XMRV to chronic fatigue syndrome, emphasizing that until Koch's postulates are fulfilled, such claims remain unproven and risk giving false hope to patients.
49:25 On Whether Viruses are Alive: Baltimore states he considers them "living" because they are part of the living world and are subject to evolution, but ultimately feels it is an unimportant semantic question rather than a scientific one.
52:51 Advice for Aspiring Scientists: His advice is candid: "You should only go into science if you can't imagine yourself doing anything else." He emphasizes that it is a difficult but necessary profession, and that basic, discovery-driven research remains absolutely essential.
1:03:25 Why Scientists Like Fishing: He explains that fly fishing, like science, is a totally absorbing activity that requires constant calculation, concentration, and problem-solving, with an element of luck.
Summary of References
1963 PNAS Paper (Poliovirus Polymerase): This paper details the discovery and characterization of the RNA polymerase induced by poliovirus infection in human cells. It was a foundational step in understanding how positive-strand RNA viruses replicate.
1963 JBC Paper (Mengovirus Polymerase): This work describes a new RNA polymerase activity found in cells infected with Mengovirus. The authors propose this enzyme is an RNA-dependent RNA polymerase responsible for duplicating the viral genome, providing a mechanism for viral replication independent of the host cell's DNA.
1970 Nature Paper (Reverse Transcriptase): This landmark paper (discussed but not listed in the description) announced the discovery of an RNA-dependent DNA polymerase (reverse transcriptase) within the virions of RNA tumor viruses. This finding proved that genetic information could flow from RNA back to DNA, profoundly impacting molecular biology and cancer research.
1975 Nobel Prize in Physiology or Medicine: David Baltimore, Renato Dulbecco, and Howard Temin were jointly awarded the prize "for their discoveries concerning the interaction between tumour viruses and the genetic material of the cell," largely for the work on reverse transcriptase and its implications.
Minor Planet 73079 Davidbaltimore: An asteroid was named in his honor, recognizing his significant contributions to science.
Glossary of Key Terms
XMRV (Xenotropic Murine Leukemia Virus-related Virus): A retrovirus that was controversially linked to Chronic Fatigue Syndrome (CFS) in a 2009 study.
The XMRV Controversy: Refers to the scientific debate following the initial link between XMRV and CFS. The original findings generated immense hope among patients but could not be replicated by other labs. It was eventually determined that the original results were due to laboratory contamination, and there is no evidence that XMRV causes CFS. Baltimore's cautious stance in the interview reflects the scientific skepticism that ultimately proved correct.
Reverse Transcriptase: An enzyme, characteristic of retroviruses (like HIV), that synthesizes DNA from an RNA template. This process, called reverse transcription, violates the classical "central dogma" of molecular biology, which stated that information flows only from DNA to RNA.
Polymerase: A general term for an enzyme whose function is to synthesize chains of nucleic acids (DNA or RNA) using an existing DNA or RNA strand as a template.
Asilomar Conference: A historic 1975 meeting where molecular biologists voluntarily established safety guidelines and a temporary moratorium on certain types of recombinant DNA experiments. It is considered a landmark example of scientific self-regulation and ethical responsibility.
Koch's Postulates: A set of four criteria designed to establish a causal relationship between a specific microbe and a specific disease. Baltimore mentions them as the gold standard for proving a virus causes a disease, a standard the XMRV-CFS link failed to meet.
Chronic Fatigue Syndrome (CFS) / Myalgic Encephalomyelitis (ME): A complex and debilitating long-term illness with a wide range of symptoms, including profound fatigue, cognitive dysfunction, and pain. Its cause remains unknown.